Published May 31, 2017 3:15pm EDT | Updated May 31, 2017 5:06pm EDT

U.S. May Have Overpaid For EpiPen By $1.3 Billion, Grassley Says

U.S. taxpayers may have overpaid for EpiPen by as much as $1.27 billion from 2006 through 2016, U.S. Sen. Chuck Grassley said Wednesday, citing an estimate from the Department of Health and Human Services Office of Inspector General. The Iowa Republican said that's far more than the $465 million that EpiPen maker Mylan agreed to in settlement negotiations with the Justice Department.